Tyrosinemia type II (Richner-Hanhart syndrome, RHS) is a disorder of a
utosomal recessive inheritance characterized by keratitis, palmoplanta
r hyperkeratosis, mental retardation, and elevated blood tyrosine leve
ls, The disease results from deficiency in hepatic tyrosine aminotrans
ferase (TAT). We have previously described one deletion and six differ
ent point mutations in four RHS patients. We have now analyzed the TAT
genes in a further seven unrelated RHS families from Italy, France, t
he United Kingdom, and the United States. We have established PCR cond
itions for the amplification of all twelve TAT exons and have screened
the products for mutations by direct sequence analysis or by first pe
rforming single-strand conformation polymorphism analysis, We have thu
s identified the presumably pathological mutations in eight RHS allele
s, including two nonsense mutations (R57X, E411X) and four amino acid
substitutions (R119W, L201R, R433Q, R433W). Only the R57X mutation, wh
ich was found in one Scottish and two Italian families, has been previ
ously reported in another Italian family. Haplotype analysis indicates
that this mutation, which involves a CpG dinucleotide hot spot, has a
common origin in the three Italian families but arose independently i
n the Scottish family. Two polymorphisms have also been detected, viz.
, a protein polymorphism, P15S, and a silent substitution S103S (TCG--
>TCA). Expression of R433Q and R433W demonstrate reduced activity of t
he mutant proteins. In all, twelve different TAT gene mutations have n
ow been identified in tyrosinemia type II.